Moore A, Collins S, Carroll D, McQuay H, Edwards J
Cochrane Pain, Palliative and Supportive Care Group, Pain Research Unit, Churchill Hospital, Old Road, Oxford, UK, OX3 7LJ.
Cochrane Database Syst Rev. 2000(2):CD001547. doi: 10.1002/14651858.CD001547.
Patient surveys have shown that postoperative pain is often not managed well, and there is a need to assess the efficacy and safety of commonly used analgesics as newer treatments become available. Paracetamol (acetaminophen) is an important non-opiate analgesic, commonly prescribed, as well as being available for retail sale. This review seeks to examine the efficacy of paracetamol alone and in combination with codeine, and also considers adverse effects.
To assess the analgesic efficacy and adverse effects of a single dose of oral paracetamol (acetaminophen) alone and in combination with codeine for moderate to severe postoperative pain.
Published trials were identified from: Medline (1966 to May 1996), Embase (1980 to 1996), Cochrane Library (Issue 2 1996) and the Oxford Pain Relief Database (1950 to 1994). Additional trials were identified from reference lists of retrieved studies. Date of most recent searches: July 1998.
Inclusion criteria were: full journal publication, postoperative pain, postoperative oral administration, adult patients, baseline pain of moderate to severe intensity, double-blind design, and random allocation to treatment groups which compared paracetamol with placebo or a combination of paracetamol and codeine with either placebo or the same dose of paracetamol alone.
Data were extracted by two independent reviewers, and trials were quality scored. Summed pain intensity and pain relief data were extracted and converted into dichotomous information to yield the number of patients with at least 50% pain relief. This was used to calculate the relative benefit and number-needed-to-treat (NNT) for one patient to achieve at least 50% pain relief over 4 to 6 hours compared with placebo. Adverse effects were used to calculate relative risk and number-needed-to-harm (NNH).
We found 40 trials of paracetamol against placebo (4171 patients), 22 trials of paracetamol plus codeine against placebo (1407 patients) and 12 trials of paracetamol plus codeine against the same dose of paracetamol (794 patients). In postoperative pain paracetamol 1000 mg had an NNT of 4.6 (3.8-5.4) for at least 50% pain relief when compared with placebo, and paracetamol 600/650 mg had an NNT of 5.3 (4.1-7.2). Paracetamol 600/650 mg plus codeine 60 mg had an NNT of 3. 6 (2.9-4.5). Comparing paracetamol plus codeine 60 mg with the same dose of paracetamol alone gave an NNT of 7.7 (5.1-17) for at least 50% pain relief. Adverse effects: Relative risk estimates for paracetamol 600/650 mg plus codeine 60 mg versus placebo showed a significant difference for 'drowsiness'/somnolence (NNH 11 (7.5- 0)) and dizziness (NNH 27 (15-164)) but no significant difference for nausea/vomiting.
REVIEWER'S CONCLUSIONS: Paracetamol is an effective analgesic with a low incidence of adverse effects. The addition of codeine 60 mg to paracetamol produces additional pain relief even in single oral doses, but may be accompanied by an increase in drowsiness and dizziness.
患者调查显示,术后疼痛往往未得到良好控制,随着新的治疗方法出现,有必要评估常用镇痛药的疗效和安全性。对乙酰氨基酚(醋氨酚)是一种重要的非阿片类镇痛药,常用于处方,也可零售。本综述旨在研究对乙酰氨基酚单独使用及与可待因联合使用的疗效,并探讨其不良反应。
评估单剂量口服对乙酰氨基酚(醋氨酚)单独使用及与可待因联合使用对中度至重度术后疼痛的镇痛效果及不良反应。
从以下数据库中检索已发表的试验:医学索引数据库(1966年至1996年5月)、医学文摘数据库(1980年至1996年)、考克兰图书馆(1996年第2期)和牛津疼痛缓解数据库(1950年至1994年)。从检索到的研究的参考文献列表中识别其他试验。最近一次检索日期:1998年7月。
入选标准为:完整的期刊发表、术后疼痛、术后口服给药、成年患者、中度至重度基线疼痛、双盲设计,以及随机分配至治疗组,将对乙酰氨基酚与安慰剂进行比较,或将对乙酰氨基酚与可待因的组合与安慰剂或单独相同剂量的对乙酰氨基酚进行比较。
由两名独立的审阅者提取数据,并对试验进行质量评分。提取疼痛强度总和及疼痛缓解数据,并将其转换为二分信息,以得出至少有50%疼痛缓解的患者数量。这用于计算与安慰剂相比,一名患者在4至6小时内实现至少50%疼痛缓解的相对获益和需治疗人数(NNT)。不良反应用于计算相对风险和需伤害人数(NNH)。
我们发现了40项对乙酰氨基酚与安慰剂对比的试验(4171名患者)、22项对乙酰氨基酚加可待因与安慰剂对比的试验(1407名患者)以及12项对乙酰氨基酚加可待因与相同剂量对乙酰氨基酚对比的试验(794名患者)。在术后疼痛中,与安慰剂相比,1000毫克对乙酰氨基酚实现至少50%疼痛缓解的NNT为4.6(3.8 - 5.4),600/650毫克对乙酰氨基酚的NNT为5.3(4.1 - 7.2)。600/650毫克对乙酰氨基酚加60毫克可待因的NNT为3.6(2.9 - 4.5)。将60毫克可待因加对乙酰氨基酚与单独相同剂量的对乙酰氨基酚进行比较,实现至少50%疼痛缓解的NNT为7.7(5.1 - 17)。不良反应:600/650毫克对乙酰氨基酚加60毫克可待因与安慰剂相比的相对风险估计显示,在“嗜睡”/昏睡(NNH 11(7.5 - 0))和头晕(NNH 27(15 - 164))方面存在显著差异,但在恶心/呕吐方面无显著差异。
对乙酰氨基酚是一种有效的镇痛药,不良反应发生率低。即使单剂量口服,在对乙酰氨基酚中添加60毫克可待因也能产生额外的疼痛缓解,但可能会伴有嗜睡和头晕的增加。